18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment. Issue 3 (March 2020) - van Schaik, Ivo N.; Mielke, Orell; Bril, Vera; Hartung, Hans-Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Durn, Billie L.; Cornblath, David R.; J. Merkies, Ingemar S.; ,